Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma
€ 15.50 · 4.8 (432) · Auf Lager
Targeting TRIP13 for overcoming anticancer drug resistance (Review)
Inhibition of EZH2 by chidamide exerts antileukemia activity and
The equilibrium of tumor suppression: DUBs as active regulators of
Frontiers FBXW7 and the Hallmarks of Cancer: Underlying
The therapeutic effects of CD24 antibody (SWA11) in xenografted
Research articles
Frontiers FBXW7 and the Hallmarks of Cancer: Underlying
Immune activation is essential for the antitumor activity of EZH2
Pathway Analysis: Most Up-to-Date Encyclopedia, News & Reviews
TRIP13 Gene - GeneCards, PCH2 Protein
Insights into a Crucial Role of TRIP13 in Human Cancer
